Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potential of Intermediate Care Units to Reduce Environmental Impact Through Sustainable Inhaler Prescribing: a Quasi-experimental Study of a Multidisciplinary Clinical Intervention

NCT07933913 is registered in ClinicalTrials.gov with Consorci Sanitari de l'Alt Penedès i Garraf as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07933913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Potential of Intermediate Care Units to Reduce Environmental Impact Through Sustainable Inhaler Prescribing: a Quasi-experimental Study of a Multidisciplinary Clinical Intervention
Lead sponsor
Consorci Sanitari de l'Alt Penedès i Garraf
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
December 31, 2028
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma (diagnosis), pulmonary disease, chronic obstructive (copd)

Arms

As registered; 2 arms.

  • delayed intervention OtherMultidisciplinary inhaler optimization intervention

    Patients of two geriatricians; usual care in periods 1 and 2, multidisciplinary inhaler intervention in period 3

  • early intervention OtherMultidisciplinary inhaler optimization intervention

    Patients of the other two geriatricians; usual care in period 1, multidisciplinary inhaler intervention in periods 2 and 3

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Percentage of prescriptions of each inhaler type At admission and at discharge from the intermediate care unit, maximal up to 1 year from admission

    Percentage of prescriptions of pressurized metered-dose inhalers (pMDI), dry powder inhalers (DPI), and soft mist inhalers (SMI) in the electronic prescription system, compared between admission and discharge in the intervention and control groups during period 2.

Lead sponsor's other trials

Consorci Sanitari de l'Alt Penedès i Garraf, most recent start first.

Similar trials

Same condition (Disease) and phase, most recent start first.